ethyl 7-(2,6-dimethoxyphenyl)-7-oxoheptanoate, 97.0%, 2g

(2R)-2-[(2-amino-6-oxo-6,9-dihydro-3H-purin-9-yl)methyl]-4,4-diethoxybutyl acetate, 97%, 25mg

N,N-Dimethyl-3-nitropyridin-2-amine, 95.0%, 5g

7-Bromo-3,4-dihydrobenzo[b]oxepin-5(2H)-one, 95.0%, 1g

2,6-Difluorophenylhydrazine, 95.0%, 10g

Isovaleric acid p-tolyl ester, 98+%, 100g

Azida de sodio, mínimo 98%, para síntesis, 2,5 kg, envase de plástico.

(4-Chloro-2,6-dimethylphenyl)boronic acid, 95.0%, 5g

4-(1H-Tetrazol-1-yl)benzohydrazide, 95.0%, 1g

Ethyl 2-benzoylbutanoate, 95%, 250mg

N,N-Diethylacetamide>99.0%(GC)25mL

1-(Benzo[d]thiazol-2-yl)ethanamine hydrochloride, 97%, 100mg

ACETAMIDE, N-[3-(4-PIPERIDINYL)PHENYL]-, 98.0%, 250mg